The Healthcare Financial Management Association (HFMA) estimates the average full marginal loss for a U.S. hospital’s treatment of sepsis amounts to as much as $34 million annually, making it one of the highest cost-containment challenges in the nation hospitals.
When sepsis care is evaluated using a condition-based economic model, the financial implications come into clear focus with the annual marginal loss: For large hospitals with more than 500 beds on average, amounts to about $34 million and for small hospitals with less than 200 beds, it averages about $9.9 million.
Direct costs reviewed under the economic model included average length of stay (LOS) and personnel time, as well as other variable costs.
The average LOS for a sepsis patient is 75% longer than for patients hospitalized for other conditions.
This longer LOS is a significant cost driver that correlates with condition severity, both in the ICU and for the overall hospital stay.Of note, ICU costs are two to three times higher than non-ICU cases, mainly because of the costs associated with personnel and therapeutics. ICU departments require higher ratios of healthcare professionals to patients, including more skilled and costly personnel.